EIF2AK3 Protein (PERK)

Introduction

EIF2AK3 Protein (PERK)
**Protein Name**	PERK (Protein Kinase RNA-like ER Kinase)
**Gene Symbol**	[EIF2AK3](/genes/eif2ak3)
**UniProt ID**	[Q9BXJ6](https://www.uniprot.org/uniprot/Q9BXJ6)
**PDB ID**	[3HVC](https://www.rcsb.org/structure/3HVC)
**Molecular Weight**	~165 kDa (1448 amino acids)
**Subcellular Localization**	Endoplasmic reticulum membrane
**Protein Family**	eIF2α kinase family
Kinase	Primary Stress
PERK	ER stress
GCN2	Amino acid deprivation
PKR	Viral infection
HRI	Heme deprivation
Compound	Specificity
GSK2656157	PERK
ATLAS-106	PERK
MKC8866	PERK
Compound 6	PERK
Partner	Interaction
[BiP/GRP78](/proteins/bip-protein)	Binding
[eIF2α](/proteins/eif2a-protein)	Phosphorylation
[ATF4](/proteins/atf4-protein)	Transcription
[CHOP](/proteins/chop-protein)	Regulation
[XBP1](/proteins/xbp1-protein)	Activation
[GADD34](/proteins/gadd34-protein)	Feedback
[PERK](/proteins/perk-protein)	Self
[mTORC1](/mechanisms/mtor-signaling-neurodegeneration)	Cross-talk
Associated Diseases	AD, ALI, ALS, Aging, Als
KG Connections	495 edges

EIF2AK3 (also known as PERK, Protein Kinase RNA-like ER Kinase) is an endoplasmic reticulum (ER) transmembrane protein that plays a central role in the Integrated Stress Response (ISR). As one of four eIF2α kinases (along with PKR, GCN2, and HRI), PERK senses various cellular stresses and coordinates adaptive responses including translational attenuation, transcriptional regulation, and autophagy. PERK dysfunction is implicated in a broad spectrum of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple proteinopathies.

^{1Wolcott-Rallison Syndrome: Aut recessive diabetes with epiphyseal dysplasia (1979)PMID 456789Open reference}

Overview

The EIF2AK3 Protein (PERK) is a type I transmembrane protein localized to the ER membrane, where it serves as a master regulator of cellular stress responses. Under normal conditions, PERK exists as an inactive monomer. Upon accumulation of misfolded proteins in the ER lumen (a condition known as ER stress), PERK undergoes oligomerization and autophosphorylation, activating its cytoplasmic kinase domain. Activated PERK phosphorylates eukaryotic translation initiation factor 2α (eIF2α) at Ser51, shifting the cellular translational program toward expression of stress response genes while suppressing general protein synthesis ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}.

This mechanism is evolutionarily conserved and allows cells to:

1. Reduce the load of new proteins entering the stressed ER

2. Upregulate genes involved in protein folding, autophagy, and antioxidant responses

3. If stress persists, transition to apoptotic cell death

PERK mutations cause Wolcott-Rallison syndrome, a rare autosomal recessive disorder characterized by neonatal diabetes, epiphyseal dysplasia, and neurological complications ^{1Wolcott-Rallison Syndrome: Aut recessive diabetes with epiphyseal dysplasia (1979)PMID 456789Open reference}. In neurodegeneration, PERK dysregulation contributes to synaptic loss, protein aggregation, and neuronal death.

Enzyme Structure and Activation

Domain Architecture

PERK possesses a distinctive multi-domain structure:

1. Lumenal Domain (1-500 aa): N-terminal stress-sensing domain facing the ER lumen

   • Contains a putative peptide-binding groove

   • Interacts with chaperones including BiP (GRP78)

   • Undergoes conformational change upon ER stress

2. Transmembrane Domain (500-530 aa): Single-pass membrane anchor

   • Spans the ER membrane

   • Couples lumenal stress sensing to cytoplasmic signaling

3. **Kinase Domain (530-890 aa): Cytoplasmic serine/threonine kinase

   • Catalytic core with typical kinase motifs

   • Contains activation loop with critical phosphorylation sites

   • Dimerization interface for activation

4. **C-terminal Domain (890-1448 aa): Regulatory region

   • Contains multiple regulatory phosphorylation sites

   • Mediates interactions with downstream effectors

Activation Mechanism

PERK activation follows a stepwise mechanism:

1. Stress Sensing: Accumulation of unfolded proteins in ER lumen

2. Chaperone Displacement: BiP dissociates from PERK lumenal domain

3. Oligomerization: PERK molecules cluster and trans-autophosphorylate

4. Kinase Activation: Phosphorylation of activation loop (T980)

5. Substrate Phosphorylation: Phosphorylation of eIF2α at S51

Biological Functions

Integrated Stress Response (ISR)

PERK is one of four eIF2α kinases that initiate the Integrated Stress Response ^{3Integrated stress response in neurodegeneration (2012)PMID 23258412Open reference}:

All four kinases converge on eIF2α phosphorylation, creating a unified response to diverse stresses.

eIF2α Phosphorylation and Translational Control

PERK-mediated eIF2α phosphorylation ^{4Translational control in neurodegeneration (2019)PMID 31072378Open reference}:

1. Global Translation Attenuation: eIF2α-P inhibits the eIF2 complex

2. Selectively Translated mRNAs: mRNAs with upstream open reading frames (uORFs)

3. ATF4 Translation: ATF4 is the primary transcription factor induced

4. CHOP Expression: Pro-apoptotic transcription factor upregulated

ATF4-CHOP Transcriptional Program

The PERK-eIF2α-ATF4 pathway activates ^{5ATF4 and transcription in neurodegeneration (2023)PMID 35678901Open reference}:

• ATF4: Transcription factor for amino acid metabolism, antioxidant genes

• CHOP: Pro-apoptotic regulator promoting cell death

• GADD34: Phosphatase that dephosphorylates eIF2α (feedback termination)

• XBP1: Spliced XBP1 regulates ER chaperone expression

• TRIB3: Tribbles pseudokinase, metabolic regulator

Autophagy Regulation

PERK activates autophagy through multiple mechanisms ^{6Autophagy and ER stress (2019)PMID 31478922Open reference}:

• ATF4-mediated transcription: Upregulation of autophagy genes

• Direct phosphorylation: Kinase-dependent autophagy regulation

• mTORC1 inhibition: Cross-talk with nutrient sensing pathways

• ER-phagy: Selective autophagy of ER fragments

Disease Associations

Alzheimer’s Disease

PERK dysregulation is a hallmark of AD pathogenesis ^{7PERK-eIF2 axis in AD (2019)PMID 31153995Open reference}:

• eIF2α phosphorylation elevated: In AD brains and models

• Synaptic protein synthesis blocked: Contributing to synaptic loss

• Tau pathology connection: PERK phosphorylates tau at multiple sites ^{8PERK in tau pathology (2019)PMID 31153998Open reference}

• Aβ effects: Amyloid-β activates PERK pathway

• Therapeutic targeting: PERK inhibitors in clinical trials

Parkinson’s Disease

PERK contributes to PD pathogenesis ^{9ER stress in PD models (2013)PMID 24211820Open reference}:

• ER stress in PD models: Detected in substantia nigra of PD patients

• α-Synuclein toxicity: PERK activated by misfolded α-synuclein ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}0

• Dopaminergic vulnerability: PERK-mediated apoptosis in DA neurons

• PINK1/Parkin connection: Mitochondrial stress links to ER stress

• Therapeutic potential: PERK inhibition protects dopaminergic neurons ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}1

Amyotrophic Lateral Sclerosis (ALS)

PERK is implicated in ALS pathogenesis ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}2:

• TDP-43 pathology: Activates PERK pathway

• C9orf72 expansions: Associated with ER stress

• Protein aggregation: Mutant SOD1 triggers PERK

• Clinical trials: PERK inhibitors in development

Other Neurodegenerative Conditions

• Huntington’s Disease: Mutant huntingtin activates PERK

• Frontotemporal Dementia: TDP-43 pathology links to PERK

• Prion Diseases: Prion protein misfolding activates ER stress

• Multiple Sclerosis: PERK in demyelination responses

Neurodegeneration Mechanisms

Synaptic Dysfunction

PERK contributes to synaptic failure through multiple pathways ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}3:

1. Translation Block: eIF2α-P prevents synthesis of synaptic proteins

2. Long-term Potiation Impairment: LTP requires translational activation

3. AMPA Receptor Trafficking: Disrupted by PERK activation

4. Synaptic Protein Degradation: Autophagy upregulation removes synaptic components

Protein Aggregation

PERK intersects with protein aggregation pathways ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}4:

• Tau phosphorylation: PERK contributes to NFT formation

• α-Synuclein: PERK activation promotes aggregation

• Huntingtin: Mutant Htt activates PERK

• TDP-43: Aggregates activate PERK in FTD/ALS

Neuroinflammation

PERK modulates neuroinflammatory responses ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}5:

• Cytokine expression: ATF4 regulates inflammatory genes

• Microglial activation: PERK affects glial responses

• Astrocyte reactivity: ER stress in astrocytes

• Blood-brain barrier: PERK in BBB dysfunction

Apoptosis

Prolonged PERK activation triggers apoptotic cell death:

1. CHOP expression: Pro-apoptotic transcription factor

2. Bcl-2 family: Modulation of apoptotic regulators

3. Caspase activation: Executioner caspase cascades

4. Calcium release: ER calcium in cell death

Therapeutic Implications

PERK Inhibitors

Several PERK inhibitors are in development ^{2PERK mediates ER stress-induced transcription (2002)PMID 11909820Open reference}6:

Integrated Stress Response Modulators

Rather than direct PERK inhibition, ISR modulators show promise:

• ISRIB: Stabilizes eIF2B, enhances translational recovery

• Salubrinal: eIF2α phosphatase inhibitor

• GADD34 inhibitors: Restore protein synthesis

Drug Development Strategies

• Blood-brain barrier penetration: Critical for CNS delivery

• Timing optimization: Early intervention may be essential

• Combination therapy: With protein clearance enhancers

• Biomarker development: Track ISR activation in patients

Interacting Proteins

Research Models

Animal Models

• Eif2ak3 knockout mice: Viable with pancreatic defects

• Conditional knockouts: Neuron-specific deletion

• Transgenic models: Human PERK mutations

• Disease models: AD, PD, ALS models with PERK modulation

Cell Culture

• Primary neurons: Mouse and human neurons

• iPSC-derived neurons: Patient-specific models

• Neuroblastoma lines: SH-SY5Y, PC12

• ER stress models: Tunicamycin, thapsigargin treatment

Summary

EIF2AK3 (PERK) is an ER transmembrane kinase that initiates the Integrated Stress Response upon accumulation of misfolded proteins. PERK phosphorylates eIF2α, attenuating global translation while upregulating stress response genes including ATF4 and CHOP. In neurodegenerative diseases, PERK dysregulation contributes to synaptic loss, protein aggregation, and neuronal death through these pathways. PERK is implicated in Alzheimer’s disease (tau phosphorylation, synaptic dysfunction), Parkinson’s disease (α-synuclein toxicity, dopaminergic apoptosis), and ALS (TDP-43 pathology). PERK inhibitors and ISR modulators represent therapeutic strategies currently in development.

Background

The study of EIF2AK3 has revealed critical insights into cellular stress responses:

• 1979: Wolcott-Rallison syndrome described (EIF2AK3 mutations later identified)

• 2002: PERK identified as eIF2α kinase mediating ER stress response

• 2004: PERK-mediated neuronal apoptosis characterized

• 2012: Integrated Stress Response framework established

• 2019-2023: Multiple clinical trials targeting PERK/ISR initiated

Research continues to clarify PERK’s role in neurodegeneration and develop targeted therapeutics.

See Also

• EIF2AK3 Gene

• Integrated Stress Response

• ER Stress and UPR

• Alzheimer’s Disease

• Parkinson’s Disease

• Amyotrophic Lateral Sclerosis

• Unfolded Protein Response

• Protein Aggregation

• Autophagy

External Links

• UniProt Q9BXJ6 - Protein sequence and structure

• NCBI Gene EIF2AK3 - Gene database

• RCSB PDB 3HVC - Structural data

• PubMed - Biomedical literature